A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies
暂无分享,去创建一个
D. Ouellet | L. D. De Zwart | J. Snoeys | J. Jiao | J. de Jong | J. Sukbuntherng | P. Hellemans | C. Panizo | T. Masterson | R. Cordoba | G. Manikhas | A. Myasnikov | V. Chauhan | D. Osmanov | S. De Wilde | D. Patricia